Question 1

What is Clopidogrel Bisulfate used for?

Accepted Answer

Clopidogrel Bisulfate is a P2Y12 Platelet Inhibitor medication tracked in Medicare Part D.

Question 2

Is there a generic for Clopidogrel Bisulfate?

Accepted Answer

Yes. 22 ANDAs filed at FDA, 15 generic manufacturers currently shipping.

Question 3

How much does my plan pay for Clopidogrel Bisulfate?

Accepted Answer

Across 329 Part D plans, Clopidogrel Bisulfate averages $0.048/unit (NADAC). Lowest available: $0.048/unit. Highest in distribution: $0.048/unit.

Question 4

Is Clopidogrel Bisulfate on the FDA shortage list?

Accepted Answer

No. Clopidogrel Bisulfate is not currently on the FDA Drug Shortage Database.

Question 5

What drug class is Clopidogrel Bisulfate in?

Accepted Answer

Clopidogrel Bisulfate is in the P2Y12 Platelet Inhibitor class. See related drugs in this class at /class/p2y12-platelet-inhibitor.

Question 6

What is the brand name for Clopidogrel Bisulfate?

Accepted Answer

Clopidogrel Bisulfate is sold under the brand name CLOPIDOGREL.

Question 7

Is CLOPIDOGREL the same as Clopidogrel Bisulfate?

Accepted Answer

Yes. CLOPIDOGREL is a brand name for Clopidogrel Bisulfate. The generic version is identical in active ingredient, dose, and FDA-approved indications. Pricing differs substantially: generic Clopidogrel Bisulfate typically prices well below brand CLOPIDOGREL.

Question 8

How much does Medicare spend on Clopidogrel Bisulfate per year?

Accepted Answer

Medicare Part D spent $243.7M on Clopidogrel Bisulfate in CY2024, across 20.5M prescriptions and 6.4M unique beneficiaries.

Question 9

What can I switch to instead of Clopidogrel Bisulfate?

Accepted Answer

Same-class alternatives include: Cangrelor, Clopidogrel, Prasugrel. Whether substitution is clinically appropriate depends on patient indication, dose schedule, and contraindications — that is a P&T committee decision. The federal data shows cost and competition; clinical equivalence is not asserted here.

Question 10

Why isn't Clopidogrel Bisulfate cheaper if there's no PA friction?

Accepted Answer

Clopidogrel Bisulfate has 15 generic manufacturers and zero prior-authorization barriers across 329 Part D plans. Why it isn't already cheaper on most plans: tier placement and PBM contract structure, not clinical or supply factors. Moving the molecule to a lower formulary tier captures the savings — see leak report for sizing.

Question 11

When did the most recent Clopidogrel Bisulfate generic get approved?

Accepted Answer

The most recent ANDA approval for Clopidogrel Bisulfate is MSN LABORATORIES PRIVATE LTD (ANDAANDA215388, approved 2024-09-20).

Question 12

When was Clopidogrel Bisulfate first FDA approved?

Accepted Answer

Clopidogrel Bisulfate received its first FDA approval on 2012-05-17.

Clopidogrel Bisulfate (CLOPIDOGREL)

$243.7M in CY2024 Part D spend20.5M claims · 6.4M beneficiaries · 329 plans surveyed

Questions a plan sponsor actually asks.

Related questions.

Same class. Different math.

Sources · every number above traces back.